Clinical Trial Update: Trial of Pegasys® in Patients With Chronic Hepatitis C [Phase 4]

View source ↗

Summary

This document reports the completion of a Phase 4 clinical trial evaluating Pegasys in patients with chronic hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Chronic Hepatitis C | Phase 4 | Status: COMPLETED